Nelson Arlin D 4
4 · MERIT MEDICAL SYSTEMS INC · Filed Mar 22, 2011
Insider Transaction Report
Form 4
Nelson Arlin D
Chief Operating Officer
Transactions
- Sale
Common Stock, No Par Value
2011-03-21$18.86/sh−8,890$167,671→ 0 total - Exercise/Conversion
Common Stock, No Par Value
2011-03-21$7.61/sh+8,890$67,653→ 8,890 total - Exercise/Conversion
Non-qualified Stock Options (right to buy)
2011-03-21−8,890→ 0 totalExercise: $7.61From: 2001-12-08Exp: 2011-12-08→ Common Stock (8,890 underlying)
Holdings
- 743(indirect: By 401(k))
Common Stock, No Par Value
- 3,500
Non-qualified Stock Options (right to buy)
Exercise: $21.67From: 2003-12-13Exp: 2013-12-13→ Common Stock (3,500 underlying) - 10,000
Non-qualified Stock Options (right to buy)
Exercise: $15.03From: 2004-12-18Exp: 2014-12-18→ Common Stock (10,000 underlying) - 1,500
Non-qualified Stock Options (right to buy)
Exercise: $13.81From: 2004-06-10Exp: 2014-06-10→ Common Stock (1,500 underlying) - 10,000
Non-qualified Stock Options (right to buy)
Exercise: $12.14From: 2005-12-28Exp: 2015-12-28→ Common Stock (10,000 underlying) - 25,000
Non-qualified stock options (right to buy)
Exercise: $14.41From: 2009-05-21Exp: 2015-05-21→ Common Stock (25,000 underlying) - 8,889
Non-qualified Stock Options (right to buy)
Exercise: $9.74From: 2003-02-06Exp: 2013-02-06→ Common Stock (8,889 underlying) - 20,000
Non-qualified Stock Options (right to buy)
Exercise: $12.13From: 2008-06-27Exp: 2014-06-27→ Common Stock (20,000 underlying)
Footnotes (4)
- [F1]Represents plan holdings as of March 21, 2011.
- [F2]Becomes exercisable in equal annual installments of 20% commencing 06/27/08.
- [F3]Becomes exercisable in equal annual installments of 20% commencing 05/21/09.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.85 to $18.92, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.